The Australian share market may be trading within sight of a record high, but that doesn't mean there aren't any cheap ASX shares out there.
For example, the two shares listed below could be undervalued and offer major upside according to analysts. Here's why they think they are cheap:
Goldman Sachs thinks that this embattled fund manager's shares have been oversold in recent months.
Especially after its funds under management (FUM) were only modestly impacted by its investments in the Adani Group. It explains:
We retain our Buy rating on GQG: We lower our PT to $2.80 from A$3.00 to reflect the relatively muted impact on flows to date despite an outsized share price reaction resulting in a year P/E of <9x. We've moderated our flows reflecting some slowdown, albeit manageable in our view.
GQG is a global asset manager with an active equity focus. We are Buy rated on GQG because: 1) Net flow trajectory has been very strong 2) Strong performance has resulted in performance fees becoming increasingly more material 3) Medium and long term relative performance strong 4) Attractive valuation vs. peers in context of very strong earnings growth. 5) Impacts from Adani appear manageable.
As mentioned above, Goldman has a buy rating and $2.80 price target on the ASX share. Based on its current share price of $2.07, this implies potential upside of 35% for investors over the next 12 months.
Analysts at Morgans think Readytech could be a cheap ASX share to buy. It is a leading software as a service (SaaS) provider of mission critical software to the tertiary education, government, justice, and enterprise markets.
Morgans believes its shares are undervalued, making it a prime example of growth at a reasonable price (GARP) on the Australian share market. It explains:
Its products include student management, payroll and HR solutions, and enterprise resource planning (ERP) to local government and legal case management. RDY's recent organic growth trajectory demonstrates its ability to deliver our forecast 14.5% CAGR EBITDA growth over coming years. Despite this, the company is trading at a ~20% discount to its historic average EBITDA multiple of ~11x, which we believe represents compelling value.
Morgans has an add rating and $3.74 price target on its shares. Based on its current share price of $3.08, this implies potential upside of 21% for investors between now and this time next year.
免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。